TLCD4

gene
On this page

Also known as FLJ31842

Summary

TLCD4 (TLC domain containing 4, HGNC:26477) is a protein-coding gene on chromosome 1p21.3, encoding TLC domain-containing protein 4 (Q96MV1).

Predicted to be involved in lipid homeostasis. Predicted to be located in membrane. Predicted to be active in endoplasmic reticulum.

Source: NCBI Gene 148534 — RefSeq curated summary.

At a glance

  • GWAS associations: 10
  • Clinical variants (ClinVar): 4 total
  • MANE Select transcript: NM_152487

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26477
Approved symbolTLCD4
NameTLC domain containing 4
Location1p21.3
Locus typegene with protein product
StatusApproved
AliasesFLJ31842
Ensembl geneENSG00000152078
Ensembl biotypeprotein_coding
Entrez148534

Gene structure

Transcript identifiers

Ensembl transcripts: 16 — 15 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000370203, ENST00000455656, ENST00000456991, ENST00000463375, ENST00000882686, ENST00000882687, ENST00000882688, ENST00000882689, ENST00000882690, ENST00000882691, ENST00000882692, ENST00000882693, ENST00000882694, ENST00000882695, ENST00000882696, ENST00000941043

RefSeq mRNA: 2 — MANE Select: NM_152487 NM_001199679, NM_152487

CCDS: CCDS753

Canonical transcript exons

ENST00000370203 — 7 exons

ExonStartEnd
ENSE000014520599519155095197607
ENSE000014520649511735595117617
ENSE000034840079517381695173889
ENSE000034861519515132595151419
ENSE000035659219514870295148791
ENSE000035838419515020895150266
ENSE000036560959514389195144056

Expression profiles

Bgee: expression breadth ubiquitous, 231 present calls, max score 96.53.

FANTOM5 (CAGE): breadth broad, TPM avg 4.7724 / max 242.8384, expressed in 910 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
41224.4756900
41230.2968127

Top tissues by expression

252 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left ventricle myocardiumUBERON:000656696.53gold quality
cardiac muscle of right atriumUBERON:000337995.79gold quality
pigmented layer of retinaUBERON:000178294.98gold quality
liverUBERON:000210794.27gold quality
myocardiumUBERON:000234993.72gold quality
right lobe of liverUBERON:000111492.79gold quality
upper leg skinUBERON:000426291.57gold quality
ileal mucosaUBERON:000033190.42gold quality
heart right ventricleUBERON:000208090.41gold quality
colonic epitheliumUBERON:000039790.19gold quality
trabecular bone tissueUBERON:000248389.56gold quality
bone marrowUBERON:000237186.74gold quality
mammalian vulvaUBERON:000099786.38gold quality
bone marrow cellCL:000209286.30gold quality
endothelial cellCL:000011585.56gold quality
epithelial cell of pancreasCL:000008385.38silver quality
colonic mucosaUBERON:000031784.35gold quality
rectumUBERON:000105284.06gold quality
cardiac atriumUBERON:000208183.83gold quality
deltoidUBERON:000147683.55gold quality
cardiac ventricleUBERON:000208283.44gold quality
heartUBERON:000094883.40gold quality
heart left ventricleUBERON:000208483.34gold quality
right atrium auricular regionUBERON:000663183.25gold quality
biceps brachiiUBERON:000150783.07gold quality
upper arm skinUBERON:000426382.95silver quality
adrenal tissueUBERON:001830382.90gold quality
vastus lateralisUBERON:000137982.45gold quality
muscle tissueUBERON:000238582.38gold quality
mucosa of sigmoid colonUBERON:000499382.34gold quality

Single-cell (SCXA)

Detected in 8 experiment(s), a significant marker in 7.

ExperimentMarker?Max mean expression
E-CURD-112yes57.19
E-MTAB-10042yes40.45
E-GEOD-135922yes16.19
E-MTAB-9388yes7.62
E-MTAB-9067yes5.80
E-HCAD-10yes3.88
E-GEOD-75367no697.97
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

293 targeting TLCD4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-5692A100.0074.406850
HSA-MIR-126-5P100.0072.713180
HSA-MIR-3163100.0077.238605
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-3646100.0073.565283
HSA-MIR-340-5P100.0072.504437
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-8485100.0077.574731
HSA-MIR-513A-5P100.0069.772465
HSA-MIR-3613-3P100.0076.367965
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-6873-3P100.0071.422626
HSA-MIR-6833-3P100.0070.633197
HSA-MIR-656-3P100.0072.152788
HSA-MIR-4668-3P100.0068.742635
HSA-MIR-4425100.0067.591049
HSA-MIR-428299.9975.366408
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-366299.9973.825684
HSA-MIR-186-5P99.9970.833707

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriosi:dkey-10f21.4ENSDARG00000057743
danio_reriotlcd4aENSDARG00000098451
mus_musculusTlcd4ENSMUSG00000028132
rattus_norvegicusTlcd4ENSRNOG00000025160

Paralogs (5): TLCD3B (ENSG00000149926), TLCD1 (ENSG00000160606), TLCD3A (ENSG00000167695), CLN8 (ENSG00000182372), TLCD2 (ENSG00000185561)

Protein

Protein identifiers

TLC domain-containing protein 4Q96MV1 (reviewed: Q96MV1)

Alternative names: Transmembrane protein 56

All UniProt accessions (3): Q96MV1, C9J6J2, C9JJM2

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Similarity. Belongs to the TLCD4 family.

RefSeq proteins (2): NP_001186608, NP_689700* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR006634TLC-domDomain
IPR050846TLCDFamily

Pfam: PF03798

UniProt features (9 total): transmembrane region 6, chain 1, domain 1, modified residue 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96MV1-F194.270.87

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 165

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 190 (showing top): RNGTGGGC_UNKNOWN, LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, IVANOVA_HEMATOPOIESIS_MATURE_CELL, GOBP_LIPID_HOMEOSTASIS, MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN, MCBRYAN_PUBERTAL_BREAST_3_4WK_UP, MCBRYAN_PUBERTAL_BREAST_5_6WK_UP, GUO_HEX_TARGETS_DN, HOOI_ST7_TARGETS_DN, LE_EGR2_TARGETS_DN, chr1p21, EVI1_04, SENESE_HDAC3_TARGETS_DN, GOBP_HOMEOSTATIC_PROCESS

GO Biological Process (1): lipid homeostasis (GO:0055088)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): endoplasmic reticulum (GO:0005783), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
chemical homeostasis1
binding1
cytoplasm1
endomembrane system1
intracellular membrane-bounded organelle1
cellular anatomical structure1

Protein interactions and networks

STRING

912 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TLCD4METTL8Q9H825647
TLCD4HEXIM2Q96MH2562
TLCD4MBOAT2Q6ZWT7496
TLCD4SMIM3Q9BZL3493
TLCD4GATA1P15976446
TLCD4CCDC74AQ96AQ1437
TLCD4NOCTQ9UK39426
TLCD4DNAJC6O75061422
TLCD4GFI1BQ5VTD9419
TLCD4ITGA2BP08514415
TLCD4LRRN4CLQ8ND94382
TLCD4HEMGNQ9BXL5370
TLCD4RWDD3Q9Y3V2369
TLCD4NRIP2Q9BQI9363
TLCD4RGS7BPQ6MZT1353

IntAct

256 interactions, top by confidence:

ABTypeScore
TMEM19TLCD4psi-mi:“MI:0915”(physical association)0.560
CHPT1TLCD4psi-mi:“MI:0915”(physical association)0.560
NKG7TLCD4psi-mi:“MI:0915”(physical association)0.560
REEP6TLCD4psi-mi:“MI:0915”(physical association)0.560
TLCD4psi-mi:“MI:0915”(physical association)0.560
EMP1TLCD4psi-mi:“MI:0915”(physical association)0.560
TMEM229BTLCD4psi-mi:“MI:0915”(physical association)0.560
BNIP3TLCD4psi-mi:“MI:0915”(physical association)0.560
EBPTLCD4psi-mi:“MI:0915”(physical association)0.560
TLCD4CLEC7Apsi-mi:“MI:0915”(physical association)0.560
TLCD4MYG1psi-mi:“MI:0915”(physical association)0.560
CYP4F22TLCD4psi-mi:“MI:0915”(physical association)0.560
FDFT1TLCD4psi-mi:“MI:0915”(physical association)0.560
CMTM5TLCD4psi-mi:“MI:0915”(physical association)0.560
TLCD4CCDC167psi-mi:“MI:0915”(physical association)0.560
TLCD4UBE2J1psi-mi:“MI:0915”(physical association)0.560
TLCD4SFXN1psi-mi:“MI:0915”(physical association)0.560
TLCD4SERP1psi-mi:“MI:0915”(physical association)0.560
FA2HTLCD4psi-mi:“MI:0915”(physical association)0.560
CXCL16TLCD4psi-mi:“MI:0915”(physical association)0.560
TMEM120BTLCD4psi-mi:“MI:0915”(physical association)0.560
COMTTLCD4psi-mi:“MI:0915”(physical association)0.560

BioGRID (117): TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Two-hybrid), TMEM56 (Two-hybrid)

ESM2 similar proteins: A2AKM2, A2AWR3, A8MR93, A8WGS4, D4A612, F1NZP5, G5EF48, O13752, O70536, P47153, Q0P5C7, Q0VD42, Q1A3B0, Q1LXV8, Q32NI8, Q3TYE7, Q4R516, Q500W7, Q57X51, Q5M8U1, Q5ND56, Q5RFL5, Q5U2T1, Q5XIY2, Q60457, Q6GLX2, Q6GNB5, Q6P4N1, Q6PGS5, Q6YWS8, Q6ZRR5, Q84QC0, Q8BHI7, Q8CGF5, Q8GYK7, Q8IU89, Q8K2C9, Q8N609, Q8QZR0, Q96CP7

Diamond homologs: O13752, Q06107, Q5UQN8, Q96MV1, P47153, Q55BP8, Q6GLX2, Q6PGS5, Q8CGF5, Q5XIY2, Q6P4N1, Q8VC26

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

4 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance2
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1715 predictions. Top by Δscore:

VariantEffectΔscore
1:95138380:G:GTdonor_gain1.0000
1:95138400:G:Tdonor_gain1.0000
1:95143885:TAACA:Tacceptor_loss1.0000
1:95143886:AACAG:Aacceptor_loss1.0000
1:95143887:ACAGG:Aacceptor_loss1.0000
1:95143888:CAG:Cacceptor_loss1.0000
1:95143888:CAGGT:Cacceptor_loss1.0000
1:95143889:A:ATacceptor_loss1.0000
1:95143890:G:Cacceptor_loss1.0000
1:95148701:GGGTA:Gacceptor_gain1.0000
1:95150206:A:AGacceptor_gain1.0000
1:95150206:AG:Aacceptor_gain1.0000
1:95150206:AGG:Aacceptor_gain1.0000
1:95150207:G:GGacceptor_gain1.0000
1:95150207:GG:Gacceptor_gain1.0000
1:95150207:GGG:Gacceptor_gain1.0000
1:95150207:GGGGT:Gacceptor_gain1.0000
1:95150264:CTGG:Cdonor_loss1.0000
1:95150267:G:Tdonor_loss1.0000
1:95150268:T:Gdonor_loss1.0000
1:95173802:T:Gacceptor_gain1.0000
1:95173814:A:AGacceptor_gain1.0000
1:95173815:G:GGacceptor_gain1.0000
1:95173886:AGCGG:Adonor_loss1.0000
1:95173887:GCG:Gdonor_gain1.0000
1:95173887:GCGGT:Gdonor_loss1.0000
1:95173888:CGG:Cdonor_loss1.0000
1:95173888:CGGT:Cdonor_loss1.0000
1:95173890:G:GAdonor_loss1.0000
1:95173890:G:GGdonor_gain1.0000

AlphaMissense

1740 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:95144046:T:AW49R0.997
1:95144046:T:CW49R0.997
1:95173870:A:CS152R0.996
1:95173872:C:AS152R0.996
1:95173872:C:GS152R0.996
1:95191626:T:CF184L0.994
1:95191628:C:AF184L0.994
1:95191628:C:GF184L0.994
1:95191766:T:AN230K0.993
1:95191766:T:GN230K0.993
1:95173884:T:AN156K0.991
1:95173884:T:GN156K0.991
1:95191773:T:AW233R0.991
1:95191773:T:CW233R0.991
1:95143944:A:CS15R0.990
1:95143946:C:AS15R0.990
1:95143946:C:GS15R0.990
1:95143980:A:CS27R0.990
1:95143982:T:AS27R0.990
1:95143982:T:GS27R0.990
1:95151381:C:GH121D0.990
1:95173850:G:CR145P0.990
1:95173868:C:TS151F0.989
1:95173889:G:CR158P0.989
1:95148702:G:CR52S0.988
1:95148702:G:TR52S0.988
1:95191639:G:CR188P0.988
1:95144048:G:CW49C0.986
1:95144048:G:TW49C0.986
1:95151325:A:CD102A0.986

dbSNP variants (sampled 300 via entrez): RS1000014289 (1:95153048 C>A,G), RS1000017455 (1:95136425 A>G), RS1000048224 (1:95136927 G>A,T), RS1000084500 (1:95101972 G>A,T), RS1000133360 (1:95193378 A>G), RS1000161443 (1:95125732 G>A), RS1000173242 (1:95114562 A>G), RS1000186695 (1:95173344 C>T), RS1000210456 (1:95143668 T>C,G), RS1000217721 (1:95173081 A>G), RS1000232835 (1:95150828 C>T), RS1000264032 (1:95151128 A>G), RS1000285317 (1:95150576 A>C), RS1000299256 (1:95173969 CAA>C), RS1000318959 (1:95131409 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

10 associations (top):

StudyTraitp-value
GCST001838_4Palmitic acid (16:0) levels3.000000e-11
GCST001840_8Stearic acid (18:0) levels2.000000e-18
GCST002701_35Verbal declarative memory9.000000e-06
GCST008103_62Bipolar disorder6.000000e-07
GCST008103_84Bipolar disorder1.000000e-06
GCST009028_33Adverse response to drug5.000000e-07
GCST009391_1620Metabolite levels4.000000e-06
GCST011125_14Caffeine consumption from coffee9.000000e-11
GCST012091_10Bipolar disorder (MTAG)1.000000e-08
GCST90002401_350Platelet distribution width8.000000e-18

EFO canonical traits (6, from GWAS)

EFO IDTrait name
EFO:0004874memory performance
EFO:0006805word list delayed recall measurement
EFO:0009658adverse effect
EFO:0010379phosphatidylcholine 36:1 measurement
EFO:0006781coffee consumption measurement
EFO:0007984platelet component distribution width

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

35 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidincreases expression, decreases methylation5
potassium chromate(VI)affects cotreatment, decreases expression2
Benzo(a)pyrenedecreases expression, increases methylation2
Nickeldecreases expression2
Aflatoxin B1decreases expression, decreases methylation2
aristolochic acid Idecreases expression1
methylmercuric chloridedecreases expression, increases expression1
trichostatin Aincreases expression1
butyraldehydedecreases expression1
epigallocatechin gallateaffects cotreatment, decreases expression1
pentanaldecreases expression1
chromium hexavalent iondecreases expression1
perfluorooctane sulfonic aciddecreases expression1
perfluoro-n-nonanoic acidaffects methylation1
entinostatincreases expression1
clothianidinincreases expression1
jinfukangdecreases expression1
Sunitinibdecreases expression1
Vorinostatincreases expression1
Calcitriolincreases expression, affects cotreatment1
Cisplatindecreases expression1
Diethylhexyl Phthalatedecreases expression1
Doxorubicindecreases expression1
Endosulfandecreases expression1
Estradiolaffects cotreatment, decreases expression1
Smokedecreases expression1
Testosteroneaffects cotreatment, increases expression1
Toluenedecreases methylation, increases expression1
Tretinoinincreases expression1
Vanadatesdecreases expression1

Cellosaurus cell lines

2 cell lines: 2 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_TT02HAP1 TMEM56 (-) 1Cancer cell lineMale
CVCL_TT03HAP1 TMEM56 (-) 2Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.